NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / World News / European drug regulator approves Moderna COVID-19 vaccine, Spikevax, for 12-17-year-olds
    European drug regulator approves Moderna COVID-19 vaccine, Spikevax, for 12-17-year-olds
    1/7
    World 3 min read

    European drug regulator approves Moderna COVID-19 vaccine, Spikevax, for 12-17-year-olds

    By Ramya Patelkhana
    Jul 24, 2021
    11:23 am
    European drug regulator approves Moderna COVID-19 vaccine, Spikevax, for 12-17-year-olds
    Credits
    European Medicines Agency has recommended authorizing Moderna’s coronavirus vaccine for children aged 12-17 years

    The European drug regulator on Friday recommended approving Moderna's coronavirus vaccine, called Spikevax, for use in children aged 12-17 years, making it the second vaccine to be authorized for this age group in the region. The European Medicines Agency (EMA) said a study involving over 3,700 children aged 12-17 years showed Spikevax triggered immune responses similar to those in young adults. Here's more.

    2/7

    This approval comes two months after Pfizer-BioNTech's jab was authorized

    Talking about the study, the Amsterdam-based European drug regulator stated, "The use of the Spikevax vaccine in children from 12 to 17 years of age will be the same as in people aged 18 and above." Notably, the decision to recommend authorization of the Moderna vaccine comes nearly two months after the Pfizer-BioNTech vaccine was approved for adolescents by the EMA in May.

    3/7

    Antibody response similar to young adults seen in 12-17-year-olds

    The EMA said Spikevax's effects were studied among a total of 3,732 children aged 12-17 years. It said the Moderna vaccine produced an antibody response similar to what was seen in young adults aged 18-25 years. "The study showed that Spikevax produced a comparable antibody response in 12- to 17-year-olds to that seen in young adults aged 18 to 25 years," the EMA said.

    4/7

    None of those administered Spikevax infected with COVID-19: Study

    The study also showed none of the participants who were administered Spikevax was infected with COVID-19; four cases were seen in the group that received dummy shots. The most common side effects observed—including pain/swelling at the injection site, fatigue, headache, nausea, vomiting, and fever—were similar to those seen in adults. The Moderna vaccine is required to be given in two doses, four weeks apart.

    5/7

    Moderna vaccine now awaits formal approval by the European Commission

    As the EMA recommended authorizing Spikevax for those aged 12-17 years, it now needs to receive formal approval by the European Commission to be administered to this age group in the European Union (EU) region. The EU Thursday said 200 million Europeans have so far been fully vaccinated—more than half the population, which is still short of its 70% target set for the summer.

    6/7

    US considering whether Moderna vaccine can be used in adolescents

    Notably, this is the first time that the Moderna vaccine has been approved by any drug regulator for use in those aged 12-17 years. Even the US Food and Drug Administration (FDA) is still studying whether its use can be extended to this age group.

    7/7

    Moderna, Pfizer now testing their vaccines in even younger children

    However, the American and European regulators have earlier warned the Moderna and Pfizer vaccines appear linked to extremely rare reactions, such as chest pain and heart inflammation, in teens and young adults. Meanwhile, both Moderna and Pfizer have already started testing their vaccines in even younger children—from those aged 11 years to six-month-old infants as well.

    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Europe
    Coronavirus
    COVID-19
    COVID-19 Vaccine
    Coronavirus Vaccine

    Europe

    EU body says it didn't receive application for Covishield approval COVID-19
    Over 40 dead, dozens missing as severe floods strike Europe Germany
    Amid rising coronavirus cases, anti-lockdown protests hit Europe Germany
    AstraZeneca's coronavirus vaccine dubbed safe; European countries to resume vaccination AstraZeneca

    Coronavirus

    Can fully vaccinated people develop long COVID? Health & Wellness
    Bharat Biotech commits to supply 500mn COVAXIN doses to Centre Bharat Biotech
    Tilak Nagar market in Delhi closed for COVID-19 protocol violation Delhi
    56 Air India staffers, including 5 pilots, died of COVID-19 Air India

    COVID-19

    COVID-19 patient, whose sample was collected for IVF, no more Gujarat
    WI-Australia second ODI postponed after positive COVID-19 test emerges Sports
    Coronavirus: India refutes reports of 'vastly undercounted' deaths Ministry of Health and Family Welfare
    Delta variant still a dominant lineage across India: INSACOG India

    COVID-19 Vaccine

    COVID-19 vaccination drive to resume from Friday in Mumbai Mumbai
    Coronavirus: India adds 4,000 more deaths as Maharashtra clears backlog Maharashtra
    Two-third of Indians have COVID-19 antibodies: ICMR serosurvey Indian Council of Medical Research (ICMR)
    No sign of Pfizer, Moderna vaccines in breast milk: Study Pfizer

    Coronavirus Vaccine

    Half of Australians under lockdown again as COVID-19 cases surge Australia
    PM Modi asks BJP leaders to counter Opposition on COVID-19 Narendra Modi
    Pfizer COVID-19 vaccine induces good immune response against coronavirus variants Pfizer
    COVAXIN overall 77.8% effective in Phase-3 trial, says Bharat Biotech COVID-19
    Next News Article

    Love World News?

    Subscribe to stay updated.

    World Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023